Acute endophthalmitis caused by Staphylococcus lugdunesis after intravitreal bevacizumab (Avastin) injection

International Ophthalmology

Volumn 29, Issue 5, 2009, Pages 411-413

  Alkuraya, Hisham S ^a   Al kharashi, Abdullah S ^a   Alharthi, Essam ^a   Chaudhry, Imtiaz A ^a  

^a King Khalid Eye Specialist Hospital   (Saudi Arabia)

Author keywords

Avastin; Bevacizumab; Endophthalmitis; Staphylococcus lugdunesis

Indexed keywords

BEVACIZUMAB; CEFTAZIDIME; DEXAMETHASONE; VANCOMYCIN;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CASE REPORT; CILIARY DISK; CORNEA REFLEX; DIABETIC PATIENT; ENDOPHTHALMITIS; EYE EXAMINATION; EYE PAIN; FEMALE; HUMAN; HUMAN TISSUE; HYPOPYON; INFECTION RISK; LENSECTOMY; NONHUMAN; REFLEX DISORDER; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; STAPHYLOCOCCUS LUGDUNENSIS; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS BIOPSY;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; FEMALE; HUMANS; INJECTIONS, INTRAOCULAR; LENS, CRYSTALLINE; MACULAR EDEMA; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 70349733500     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-008-9237-z     Document Type: Article

References (9)

1. Ferrara N, Hillan KJ, Gerber HP et al (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391-400
2. Melvin DR, Dante JP, Alessandero AC et al (2007) Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondry to branch retinal vein occlusion. Retina 27:419-425
3. Jaissle GB, Ziemssn F, Petermeier K et al (2006) Bevacizumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 113:363-372
4. Iturralde D, Spaid RF, Mayerle CB et al (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26:279-284
5. Rosenfeld PJ, Fung AE, Puliafito CA (2005) Optical coherence tomography finding after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36:336-339
6. Jonas JB, Spandau UH, Rensch F (2007) Infectious and noninfectious endophthalmitis after intravitreal bevacizumab. J Ocul Pharmacol Ther 23:240-242
7. Fung AE, Rosenfeld PJ, Reichel E (2006) The international intravitreal bevacizumab safety survey: Using the internet to assess drug safety worldwide. Br J Ophthalmol 90:1344-1349
8. Aggio FB, Farah ME, de Melo GB et al (2007) Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection. Eye 21:408-409
9. Chiquet C, Pechinot A, Creuzot-Garcher C et al (2007) Acute postoperative endophthalmitis caused by Staphylococcus lugdunesis. J Clin Microbiol 45:1673-1678